HER2阳性-话题@MedSci

#HER2阳性#

183篇内容 | 2407人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1308448, encodeId=1635130844858, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, objectTitle=NEJM：在HER2阳性乳腺癌中的曲妥珠单抗辅助治疗, objectType=article, longId=3189, objectId=acf73189d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acf73189d5, replyNumber=0, likeNumber=0, createdTime=2011-10-17, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acf73189d5, moduleTitle=NEJM：在HER2阳性乳腺癌中的曲妥珠单抗辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acf73189d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308447, encodeId=4665130844ed3, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, objectTitle=HER2阳性乳腺癌新辅助治疗探讨, objectType=article, longId=2658, objectId=7d742658f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d742658f8, replyNumber=0, likeNumber=42, createdTime=2011-06-09, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d742658f8, moduleTitle=HER2阳性乳腺癌新辅助治疗探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d742658f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308446, encodeId=053d1308446c7, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, objectTitle=HER2阳性早期乳腺癌化疗后辅助曲妥珠单抗有益, objectType=article, longId=2441, objectId=3f03244110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f03244110, replyNumber=0, likeNumber=35, createdTime=2011-04-04, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f03244110, moduleTitle=HER2阳性早期乳腺癌化疗后辅助曲妥珠单抗有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f03244110)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308445, encodeId=50ad130844596, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, objectTitle=Lancet:曲妥单抗联合化疗VS普通化疗治疗HER2阳性晚期胃癌或食管胃结合部腺癌：3期随机对照开放试验, objectType=article, longId=2195, objectId=5ea1219596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ea1219596, replyNumber=0, likeNumber=38, createdTime=2010-10-15, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ea1219596, moduleTitle=Lancet:曲妥单抗联合化疗VS普通化疗治疗HER2阳性晚期胃癌或食管胃结合部腺癌：3期随机对照开放试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ea1219596)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HER2阳性

2020-05-29

闆锋旦 (审核中...)

前往app查看评论内容

#HER2阳性#

NEJM：在HER2阳性乳腺癌中的曲妥珠单抗辅助治疗

2011-10-17

闆锋旦 (审核中...)

前往app查看评论内容

#HER2阳性#

HER2阳性乳腺癌新辅助治疗探讨

2011-06-09

闆锋旦 (审核中...)

前往app查看评论内容

#HER2阳性#

HER2阳性早期乳腺癌化疗后辅助曲妥珠单抗有益

2011-04-04

闆锋旦 (审核中...)

前往app查看评论内容

#HER2阳性#

Lancet:曲妥单抗联合化疗VS普通化疗治疗HER2阳性晚期胃癌或食管胃结合部腺癌：3期随机对照开放试验

2010-10-15

科室
- - 订阅+
  - 更多科室
工具
服务